European stocks opened lower, European Stoxx 50 index fell 0.15%, European stocks opened lower, European Stoxx 50 index fell 0.15%, German DAX index fell 0.03%, British FTSE 100 index fell 0.3%, and French CAC40 index fell 0.3%.The interest rate of active bonds of 10-year and 30-year treasury bonds went down by more than 2bp, and the yield of main inter-bank interest bonds went down. The interest rate of 10-year treasury bonds went down by 2.15bp to 1.82%. The interest rate of 30-year national debt 2400006 fell by 2.15bp to 2.3075%; In 10 years, the interest rate of CDB 240215 dropped by 2.65bp to 1.886%.On the 11th, the 10-year treasury bond futures fell by 0.09%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract 10-year treasury bond futures closed at 2503, up or down by -0.09%, with a turnover of 65,600 lots. The position data showed that the top 20 seats were clear, and the difference position was 4,068 lots. The total number of 10-year treasury bond futures contracts was 69,300 lots, a decrease of 26,600 lots from the previous day. The first 20 seats in the contract held 176,000 lots, a decrease of 3,678 lots from the previous day. The short positions in the top 20 seats of the contract were 181,200 lots, a decrease of 713 lots from the previous day. (Sina Futures)
Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.The Israeli army warned Lebanese residents not to move to southern Lebanon. On the 11th local time, Adrahi, Arabic spokesperson of the Israel Defense Forces, posted a message on the social media platform, asking Lebanese residents not to move to more than 60 villages and their surrounding areas in southern Lebanon until further notice. The Israeli army provided a schematic diagram of the warning area and warned that anyone moving south of the area would put himself in danger. (CCTV News)Sichuan Bank successfully issued 5.4 billion tier-2 capital bonds for the first time, with a subscription multiple of 6.6 times. Sichuan Bank completed its first capital bond issuance on December 10th. According to the information released by China Foreign Exchange Trading Center, the scale of Tier 2 capital bonds issued by Sichuan Bank this time is 5.4 billion yuan, and the subscription multiple is as high as 6.6 times, while that of coupon rate is 2.20%, with a term of 5+5 years. This bond attracted more than 100 institutional investors including banks, brokers, funds, trusts and wealth management subsidiaries to participate in the subscription, with a cumulative investment of more than 35 billion yuan.
The Taiwan Affairs Office of the State Council introduced the annual meeting of the 2024 Cross-Strait Entrepreneur Summit. Zhu Fenglian, a spokesperson for the Taiwan Affairs Office, said that the 2024 Cross-Strait Entrepreneur Summit was successfully held in Xiamen, Fujian from December 9 to 10. More than 700 business people from both sides of the Taiwan Strait attended the annual summit. Focusing on the theme of "Building a new era industrial chain across the Taiwan Strait to promote cross-strait economic integration and development", they conducted in-depth discussions on issues such as promoting cross-strait industrial Internet innovation, building Taiwanese enterprises to land in their first homes, and innovating cross-strait financial service systems. The exchange atmosphere was warm, which fully demonstrated the common aspiration of cross-strait industries to strengthen exchanges and cooperation. (Riyue Tan Tian)Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.Hailiang shares: 325,700 shares of the company were repurchased for the first time. Hailiang shares announced that on December 10, 2024, the company repurchased 325,700 shares through a special account for stock repurchase, accounting for 0.0163% of the company's total share capital. The highest transaction price was 10.86 yuan/share, the lowest transaction price was 10.52 yuan/share, and the total transaction amount was 3,518,700 yuan. This repurchase conforms to the requirements of the company's repurchase plan and relevant laws and regulations.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14